Market participants engaging with this technology deserve clear regulatory rules of the road,” Atkins said during a ...

In his first public appearance as SEC chairman, Paul Atkins opened the latest crypto roundtable in the agency's Washington headquarters.

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission ...

Elevation Oncology, Inc. , an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

The new head of the U.S. Securities and Exchange Commission on Friday said that the agency has stifled innovation for the ...

A highly specific taxonomy is needed for the U.S. to move forward with crypto regulation, the company argued in a letter to ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 abstracts, including one oral presentation, have ...